At a glance
- Originator NovaDel Pharma
- Class Antiallergics; Antipruritics; Pyrrolidines; Sedating antihistamines
- Mechanism of Action Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Seasonal allergic rhinitis
Most Recent Events
- 12 Feb 2008 Discontinued - Phase-II for Seasonal allergic rhinitis in USA (Transmucosal)
- 15 Nov 2004 Suspended - Phase-II for Seasonal allergic rhinitis in USA (Sublingual)
- 20 Nov 2000 Phase-II clinical trials for Seasonal allergic rhinitis in USA (Sublingual)